• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911408250
Device Problem Occlusion Within Device (1423)
Patient Problems Angina (1710); Reocclusion (1985)
Event Date 03/24/2017
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr.: it is indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.(b)(4).
 
Event Description
Promus element plus clinical study.It was reported that angina and in-stent restenosis (isr) occurred.In (b)(6) 2013, the patient presented due to stable angina and was referred for cardiac catheterization.Subsequently, the index procedure was performed.Target lesion #1 was a de novo lesion located from distal saphenous vein graft (svg) to 1st diagonal branch with 70% stenosis and was a 4 mm long with a reference vessel diameter of 2.5 mm.The lesion was treated with pre-dilatation and placement of a 2.50 x 8 mm pe plus stent 0% residual stenosis.Target lesion #2 was a de novo lesion located from proximal svg to 1 st diagonal with 90% stenosis and was a 14 mm long with a reference vessel diameter of 3.0 mm.Target lesion #2 was treated with direct placement of a 3.00 x 16 mm pe plus stent with 0% residual stenosis.The next day, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2017, the patient presented with worsening symptoms of stable angina.The patient experienced symptoms of angina with very little activity for the past few weeks.Cardiac catheterization was recommended.In (b)(6) 2017, cardiac catheterization revealed a 99% stenosis and 50% isr of study stent located at distal portion of svg to 1st diagonal branch and was treated with predilatation and placement of 2.5 x 18 mm and 3.0 x 12 mm non-bsc stents in an overlapping fashion.Following post dilatation, there was 0% residual stenosis and timi 3 flow.A day after, the event was considered to be resolved and the patient was discharged from the hospital.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key7278256
MDR Text Key100317349
Report Number2134265-2018-01032
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 01/25/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/16/2013
Device Model NumberH7493911408250
Device Catalogue Number39114-0825
Device Lot Number15805404
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/25/2018
Initial Date FDA Received02/16/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/23/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
-
-